Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-14-042457
Filing Date
2014-06-18
Accepted
2014-06-18 20:48:35
Documents
1
Period of Report
2014-06-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 7904
  Complete submission text file 0001209191-14-042457.txt   9336
Mailing Address C/O ALNYLAM PHARMACEUTICALS, INC. 300 THIRD STREET CAMBRIDGE MA 02142
Business Address
Barrett Peter (Reporting) CIK: 0001291895 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36510 | Film No.: 14929306

Mailing Address ONE BROADWAY, 8TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY, 8TH FLOOR CAMBRIDGE MA 02142 (617 ) 401-3051
ZAFGEN, INC. (Issuer) CIK: 0001374690 (see all company filings)

EIN.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations